Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis
International Journal of Molecular Sciences · 07.02.2023 · 24 (4) · 3254
DOI: 10.3390/ijms24043254 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.02.2023. Verfasst von Yung-Heng Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Bone and Joint Research Center, Chang Gung Memorial Hospital, Tao-Yuan 33305, Taiwan. Hauptthemen laut MEDLINE: Nanofibers, Osteomyelitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Linkou Chang Gung Memorial Hospital, National Science and Technology Council, Taiwan, Chang Gung Memorial Hospital-Linkou.
Abstract (Originalsprache)
This study aimed to develop a drug delivery system with hybrid biodegradable antifungal and antibacterial agents incorporated into poly lactic-co-glycolic acid (PLGA) nanofibers, facilitating an extended release of fluconazole, vancomycin, and ceftazidime to treat polymicrobial osteomyelitis. The nanofibers were assessed using scanning electron microscopy, tensile testing, water contact angle analysis, differential scanning calorimetry, and Fourier-transform infrared spectroscopy. The in vitro release of the antimicrobial agents was assessed using an elution method and a high-performance liquid chromatography assay. The in vivo elution pattern of nanofibrous mats was assessed using a rat femoral model. The experimental results demonstrated that the antimicrobial agent-loaded nanofibers released high levels of fluconazole, vancomycin, and ceftazidime for 30 and 56 days in vitro and in vivo, respectively. Histological assays revealed no notable tissue inflammation. Therefore, hybrid biodegradable PLGA nanofibers with a sustainable release of antifungal and antibacterial agents may be employed for the treatment of polymicrobial osteomyelitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Bone and Joint Research Center, Chang Gung Memorial Hospital, Tao-Yuan 33305, Taiwan.
- Department of Mechanical Engineering, Chang Gung University, Tao-Yuan 33302, Taiwan.
ORCID-Profile: Yung-Heng Hsu, Shih-Jung Liu
Förderung
- Linkou Chang Gung Memorial Hospital
- National Science and Technology Council, Taiwan
- Chang Gung Memorial Hospital-Linkou
Zitieren
APA
Hsu, Y. H., Yu, Y. H., Chou, Y. C., Lu, C. J., Lin, Y. T., Ueng, S. W., & Liu, S. J. (2023). Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis. International Journal of Molecular Sciences, 24(4), 3254. https://doi.org/10.3390/ijms24043254
Vancouver
Hsu YH, Yu YH, Chou YC, Lu CJ, Lin YT, Ueng SW, et al. Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis. International Journal of Molecular Sciences. 2023;24(4):3254. doi:10.3390/ijms24043254
BibTeX
@article{Hsu2023,
author = {Hsu, Yung-Heng and Yu, Yi-Hsun and Chou, Ying-Chao and Lu, Chia-Jung and Lin, Yu-Ting and Ueng, Steve Wen-Neng and Liu, Shih-Jung},
title = {Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3254},
doi = {10.3390/ijms24043254}
}
EUVIMED